Fevac® 5 Vaccine

Description:

Inactivated vaccine prepared from feline panleucopenia (feline enteritis) virus, feline rhinotracheitis virus (feline herpesvirus type 1), feline calicivirus and Chlamydophila psittaci and feline leukaemia virus (FeLV) antigen gp70. Fevac^® F5 contains a water-soluble adjuvant to enhance the immune response.

Recommendations for use:

An inactivated vaccine for the active immunisation of healthy cats 8 weeks of age or older to aid in the reduction of clinical symptoms caused by infection with feline rhinotracheitis virus, feline calicivirus, panleucopenia virus, Chlamydophila felis and feline leukaemia virus

Pack sizes:

Injection, single dose 1 mL vial: 20’s.

SDS

• Effective and well tolerated for routine use in kittens, queens and adult cats
• Being a killed vaccine, ideal for use in multi-cat environments – no risk of disease being passed to other cats in the household
• No risk of vaccine-induced respiratory disease or the chronic carrier state- considered to be the preferred type of vaccine
• Non-aluminium, water soluble adjuvant for enhanced immunity
• Convenience of vaccination against 5 diseases including Chlamydia and FeLV in a single dose

Dosage:

Fevac®  F5 may be administered to cats aged 8 weeks and older, administer two 1 mL doses of the vaccine subcutaneously given at an interval of 3-4 weeks. Recommended that an annual booster with a single dose of vaccine be administered.

Storage:

Store between 2°C and 8°C (Refrigerate. Do not freeze). Protect from light.

Human Safety

Additional user safety

Take care to avoid accidental self-injection. In the event of self-administration, seek prompt medical attention and take this package leaflet/carton with you. If possible the application of gentle squeezing pressure with absorbent material (e.g. facial tissues) at the injection site will swab up unabsorbed vaccine. Strong squeezing of the site should be avoided. The damaged area should be thoroughly cleansed and a topical antiseptic applied.

Accidental self-administration may result in local bruising, severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If pain persists for more than 12 hours after medical examination, seek medical advice again.

First Aid Statement

If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126.

This material may cause a mild allergic reaction in sensitive individuals on skin contact. Avoid skin contact. If skin or hair contact occurs, remove contaminated clothing and flush skin and hair with running water. If splashed in eyes, wash out immediately with water.

Registered label warnings

Side Effects

Some animals may show transient post-vaccination reactions including pain, malaise, lethargy, inappetence, transient fever, depression and/or stiffness. These reactions usually disappear within 24-48 hours. Allergic reactions such as anaphylaxis occur rarely and may require parenteral treatment with an antihistamine, a corticosteroid or adrenalin as appropriate. Local site reactions after vaccination are rare but transient swelling, pain and subcutaneous thickening may occur.

Based on overseas challenge data, it has been demonstrated that clinical signs of feline calicivirus infection (pyrexia, ulcers) are likely to occur in vaccinated animals following exposure to this virus. However the severity of the fever and ulcers is likely to be reduced compared to unvaccinated animals.

Precautions

Vaccinate only healthy cats or kittens with normal temperatures. Animals under treatment with immunosuppressive drugs should be vaccinated with caution. Studies to support the use of the product in pregnant queens have not been conducted.

Additional Information

Fevac F4 vaccine is an inactivated vaccine.

This vaccine does not prevent infection or shedding.